A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients
NCT06082557
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
62
Enrollment
OTHER
Sponsor class
Conditions
Malignant Solid Tumors
Interventions
DRUG:
T60c injection
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences